Using machine learning to understand severe pneumonia caused by COVID-19.
Modeling Core
This study is looking at how advanced computer techniques can help us understand severe pneumonia caused by COVID-19, with the goal of finding new ways to improve treatment and care for patients like you.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Northwestern University at Chicago NIH-funded |
| Lab location | 1 site (Chicago, United States) |
| Project ID | NIH-11014080 on NIH RePORTER |
What this research studies
This research focuses on applying advanced machine learning techniques to analyze clinical and biological data related to severe pneumonia, particularly that caused by the SARS-CoV-2 virus. By leveraging a systems biology approach, the project aims to develop detailed models that explain the unique host responses associated with COVID-19 pneumonia. The research also seeks to identify new biomarkers and therapeutic targets that could improve treatment outcomes for patients suffering from severe pneumonia. Through the collection of various biological samples and deep clinical phenotyping, the study aims to enhance clinical decision-making for affected patients.
Who could benefit from this research
Good fit: Ideal candidates for this research include patients diagnosed with severe pneumonia caused by SARS-CoV-2.
Not a fit: Patients with mild pneumonia or pneumonia caused by pathogens other than SARS-CoV-2 may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatment strategies and better patient outcomes for those suffering from severe pneumonia due to COVID-19.
How similar studies have performed: Other research has shown promise in using machine learning to analyze pneumonia data, but this specific approach focusing on COVID-19 is relatively novel.
Where this research is happening
Chicago, United States
- Northwestern University at Chicago — Chicago, United States (Active)
Researchers
- Principal investigator: Amaral, Luis a. Nunes — Northwestern University at Chicago
- Study coordinator: Amaral, Luis a. Nunes
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.